Vertex Pharmaceuticals, Inc. (VRTX)
542.62
-4.41
(-0.81%)
USD |
NASDAQ |
Nov 12, 16:00
545.00
+2.38
(+0.44%)
After-Hours: 04:13
Vertex Pharmaceuticals Price : 542.62 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 547.87 | 552.27 | 542.51 | 542.62 | 984588.0 |
| Nov 11, 2026 | 543.96 | 548.67 | 535.46 | 547.03 | 1.079M |
| Nov 10, 2026 | 546.96 | 551.86 | 543.44 | 547.89 | 1.239M |
| Nov 09, 2026 | 555.99 | 555.99 | 538.48 | 550.87 | 1.214M |
| Nov 06, 2026 | 531.53 | 548.76 | 531.53 | 547.09 | 1.272M |
| Nov 05, 2026 | 556.85 | 557.85 | 540.02 | 542.50 | 2.483M |
| Nov 04, 2026 | 535.63 | 550.77 | 527.38 | 549.04 | 1.833M |
| Nov 03, 2026 | 558.44 | 561.96 | 529.15 | 530.76 | 2.374M |
| Nov 02, 2026 | 560.88 | 568.67 | 544.09 | 553.15 | 3.208M |
| Oct 30, 2026 | 550.73 | 563.80 | 549.89 | 558.88 | 3.030M |
| Oct 29, 2026 | 536.46 | 546.61 | 534.01 | 540.00 | 1.542M |
| Oct 28, 2026 | 514.45 | 534.94 | 513.37 | 529.69 | 1.285M |
| Oct 27, 2026 | 514.84 | 521.43 | 509.20 | 521.03 | 1.020M |
| Oct 26, 2026 | 526.86 | 529.66 | 509.33 | 517.49 | 1.189M |
| Oct 23, 2026 | 531.66 | 533.08 | 522.91 | 523.93 | 832628.0 |
| Oct 22, 2026 | 527.18 | 537.81 | 521.30 | 535.17 | 1.642M |
| Oct 21, 2026 | 512.79 | 528.57 | 510.48 | 524.52 | 1.449M |
| Oct 20, 2026 | 507.89 | 515.74 | 505.00 | 514.65 | 1.231M |
| Oct 19, 2026 | 500.00 | 505.83 | 499.50 | 501.95 | 1.299M |
| Oct 16, 2026 | 511.06 | 512.21 | 497.49 | 499.74 | 1.413M |
| Oct 15, 2026 | 514.91 | 517.68 | 507.21 | 508.75 | 2.263M |
| Oct 14, 2026 | 490.45 | 502.94 | 487.54 | 498.50 | 2.090M |
| Oct 13, 2026 | 507.55 | 508.57 | 484.08 | 485.22 | 1.188M |
| Oct 12, 2026 | 512.44 | 514.80 | 506.00 | 507.00 | 952749.0 |
| Oct 09, 2026 | 502.11 | 514.90 | 502.06 | 510.08 | 1.481M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Gilead Sciences, Inc. | 167.95 |
| Regeneron Pharmaceuticals, Inc. | 951.19 |
| Sionna Therapeutics, Inc. | 3.43 |
| Amgen, Inc. | 467.06 |
Price Related Metrics
| PE Ratio | 34.90 |
| PS Ratio | 10.65 |
| PEG Ratio | 3.650 |
| Price to Book Value | 6.580 |
| Price to Free Cash Flow | 43.33 |
| Earnings Yield | 2.86% |
| Market Cap | 137.57B |
| PEGY Ratio | 3.650 |
| Operating PE Ratio | 30.49 |
| Normalized PE Ratio | 33.83 |